9-(4-Bromonaphthalen-1-yl)-10-phenylanthracene

Catalog No.: 
ACUJTE505
CAS No.: 
1062556-32-4
Molecular Formula: 
C30H19Br
Molecular Weight: 
459.39
9-(4-Bromonaphthalen-1-yl)-10-phenylanthracene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$237.00InquiryInquiry
25g97%$939.00InquiryInquiry
100g97%$3718.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name9-(4-Bromonaphthalen-1-yl)-10-phenylanthracene
IUPAC Name9-(4-bromonaphthalen-1-yl)-10-phenylanthracene
Molecular FormulaC30H19Br
Molecular Weight459.39
SMILESBrC1=C2C=CC=CC2=C(C3=C4C=CC=CC4=C(C5=CC=CC=C5)C6=CC=CC=C36)C=C1
InChI KeyAWBVADGVTVEIMG-UHFFFAOYSA-N
SynonymPA1NBA-B;9-(4-bromonaphthalen-1-yl)-10-phenylanthracene;9-(4-bromo-1-naphthalenyl)-10-phenyl- Anthracene;Anthracene, 9-(4-bromo-1-naphthalenyl)-10-phenyl-
CAS No.1062556-32-4

Synthetic Route by SureRoute

1. ACUJTE505 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHOYQ807 route compound structure diagram
    ACHOYQ80783-53-4In Stock
  2. Plus
  3. ACQJED218 route compound structure diagram
    ACQJED218334658-75-2In Stock
  4. Then
  5. ACUJTE505 route product structure diagram
    ACUJTE5051062556-32-4
Inquiry

2. ACUJTE505 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACATWM763 route compound structure diagram
    ACATWM76323674-20-6In Stock
  2. Plus
  3. ACFDCN381 route compound structure diagram
    ACFDCN38163279-58-3In Stock
  4. Then
  5. ACUJTE505 route product structure diagram
    ACUJTE5051062556-32-4
Inquiry

3. ACUJTE505 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6In Stock
  4. Then
  5. ACUJTE505 route product structure diagram
    ACUJTE5051062556-32-4
Inquiry

Comments (0)